Profil
Yael Hayon formerly worked at Stem Cell Medicine Ltd., as Manager-Research & Development from 2014 to 2016, Syqe Medical Ltd., as Vice President-Clinical Affairs, LogicBio Therapeutics, Inc., as Head-Research & Development from 2016 to 2020, and Protalix Biotherapeutics, Inc., as Vice President-Research & Development from 2020 to 2024.
Dr. Hayon received her graduate degree and doctorate degree from The Hebrew University of Jerusalem.
Ehemalige bekannte Positionen von Yael Hayon
| Unternehmen | Position | Ende |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2024 |
| LOGICBIO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
Stem Cell Medicine Ltd.
Stem Cell Medicine Ltd. Pharmaceuticals: OtherHealth Technology Provides therapeutic technology in combination with medication | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 |
Syqe Medical Ltd.
Syqe Medical Ltd. Medical SpecialtiesHealth Technology Develops metered-dosed cannabis inhaler | Corporate Officer/Principal | - |
Ausbildung von Yael Hayon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Stem Cell Medicine Ltd.
Stem Cell Medicine Ltd. Pharmaceuticals: OtherHealth Technology Provides therapeutic technology in combination with medication | Health Technology |
Syqe Medical Ltd.
Syqe Medical Ltd. Medical SpecialtiesHealth Technology Develops metered-dosed cannabis inhaler | Health Technology |
LogicBio Therapeutics, Inc.
LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
















